Ozempic vs. Mounjaro: The Short Answer
Ozempic and Mounjaro are both once-weekly injections approved for type 2 diabetes, and both lower blood sugar and body weight. The drug inside Ozempic is semaglutide; the drug inside Mounjaro is tirzepatide. Each has a sister brand approved for chronic weight management: Wegovy is semaglutide, and Zepbound is tirzepatide.
The headline difference is that tirzepatide acts on two gut hormone receptors instead of one, and in head-to-head trials it produced greater average weight loss and, in type 2 diabetes, greater A1c reduction. Semaglutide has a longer track record and FDA-approved heart benefits. Neither is right for everyone, and the best choice depends on your goals, your heart and kidney history, how you tolerate side effects, and what your plan covers.
How Each Medicine Works
After a meal, your gut releases hormones called incretins that tell the pancreas to release insulin, slow stomach emptying, and signal fullness to the brain.
- Semaglutide mimics one incretin, GLP-1.
- Tirzepatide mimics GLP-1 and a second hormone, GIP, which appears to add to the effect on blood sugar and appetite.
Both lower blood sugar mainly when it is high, so on their own they rarely cause low blood sugar. That changes when they are combined with insulin or sulfonylureas such as glipizide, which often need to be reduced. The NIDDK overview of diabetes medicines explains where these fit among other options.
Approved Uses Compared
Semaglutide brands
- Ozempic: type 2 diabetes, plus lowering the risk of heart attack, stroke, and cardiovascular death in people with diabetes and heart disease, and slowing kidney disease in people with diabetes and chronic kidney disease
- Wegovy: chronic weight management, plus lowering cardiovascular risk in people with heart disease and obesity or overweight
- Rybelsus: a daily tablet form for type 2 diabetes
Tirzepatide brands
- Mounjaro: type 2 diabetes
- Zepbound: chronic weight management, and moderate to severe obstructive sleep apnea in adults with obesity
Approved uses for this class keep expanding, so we check current labeling when we prescribe. The MedlinePlus pages for semaglutide and tirzepatide summarize the details.
Weight Loss and Blood Sugar
In clinical trials, both medicines produced weight loss far beyond what earlier diabetes drugs achieved, and tirzepatide produced more on average when the two were compared directly. Averages hide a wide range, though: some people lose more on semaglutide than the average tirzepatide user, and a few lose little on either.
Two points apply to both:
- The effect lasts only while you take it. Most people regain much of the weight within a year of stopping, which is why these are usually long-term treatments.
- Weight loss includes some muscle. Eating enough protein and doing resistance exercise helps protect strength, especially after 60.
Side Effects and Safety
The side effects are similar because the mechanisms overlap. Nausea, vomiting, diarrhea, constipation, and reduced appetite are most common, and they are worst in the weeks after starting or increasing the dose, which is why both are started low and raised gradually. Our article on managing GLP-1 side effects has practical tips.
Warnings that apply to both
- Thyroid tumors: both carry a boxed warning based on animal studies. Do not use them if you or a family member has had medullary thyroid cancer or MEN 2 syndrome.
- Pancreatitis and gallbladder problems: severe, persistent abdominal pain needs prompt evaluation.
- Procedures and anesthesia: both slow stomach emptying, so tell your surgeon and anesthesia team before any procedure.
- Pregnancy: neither is used during pregnancy; plan ahead with us if you hope to conceive.
A difference that matters for some women
Tirzepatide can make birth control pills less reliable. Its labeling advises switching to a non-oral method or adding a backup method for four weeks after starting and after each dose increase.
Choosing Between Them
- Do you have heart disease? Semaglutide has FDA-approved cardiovascular risk reduction, which often tips the decision.
- Is maximum weight loss the main goal? Tirzepatide has the edge on average.
- Do you have sleep apnea with obesity? Zepbound has a specific approval.
- What does your plan cover? Coverage varies by plan and by the reason the drug is prescribed, and it often decides the question in practice.
Be wary of unapproved and compounded versions sold online. The FDA has warned about unapproved GLP-1 drugs, including dosing errors and products that are not what they claim to be. Our GLP-1 medication program uses FDA-approved products with regular follow-up.
Florida Considerations
Unopened pens need refrigeration, which makes hurricane season a real planning issue. Our guide to keeping refrigerated medicines safe in a power outage covers what to do. Summer heat also makes dehydration easier, and vomiting or diarrhea from these medicines can quickly add to it.
When to See Your Doctor
- Severe abdominal pain that does not go away, with or without vomiting
- Vomiting or diarrhea that keeps you from holding down fluids
- Symptoms of low blood sugar if you also take insulin or a sulfonylurea
- A lump or swelling in the neck, hoarseness, or trouble swallowing
- Pain in the upper right abdomen, fever, or yellowing of the skin or eyes
- An upcoming surgery or procedure, or plans to become pregnant
Trying to decide between Ozempic, Mounjaro, or another option? Schedule a visit and we will match the medicine to your health goals and coverage.
